Tag: trial
Luminor anticipated to have a “big impact” on the Japanese market...
NOTE: This video is ONLY available to watch in selected countries and geographies
Yoshimitsu Soga (Fukuoka, Japan) spoke to Vascular News at the Leipzig...
EDDA Technology announces trial agreement with SIO
EDDA Technology, a provider of advanced imaging-guided precision treatment solutions, announced it has entered into an agreement with the Society of Interventional Oncology (SIO)...
Thrombolex announces “very exciting” interim RESCUE results
Thrombolex recently announced the results of the RESCUE trial’s prespecified interim analysis, of the first 62 evaluable patients, in a late-breaking clinical trials session...
US IDE trial finds embolization “safe and efficacious” for benign prostatic...
A prospective US FDA-approved investigational device exemption (IDE) study has demonstrated significant improvement in lower urinary tract symptoms secondary to benign prostatic hyperplasia and...
Theoretical benefit with microwave ablation “does not translate into clinical benefit”...
A prospective randomised controlled study that compared outcomes between hepatocellular carcinoma patients who were treated by microwave ablation with those who were treated by...
Randomised trial finds prostatic artery embolization “a real treatment alternative” to...
Six-month results from a prospective, randomised, non-inferiority study presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE; 16–20 September, Copenhagen, Denmark) reveal...
iVascular initiates TINTIN Luminor trial
iVascular SLU has announced the initiation of the TINTIN trial, evaluating the combined therapy of Luminor drug-coated balloon (DCB) and iVolution self-expandable stent.
The TINTIN...
Vast majority of patients prefer radial access for embolization therapies in...
“While both radial and femoral accesses are safe and effective for transarterial liver embolization, it is clear that the patients prefer radial access,” said Marcelo Guimaraes, Charleston, USA, who was presenting on the...
CAVA trial to shed light on clinical and cost-effectiveness of routinely...
The world’s largest randomised trial comparing three central venous access devices—peripherally inserted central catheters (PICCs), Hickman-type devices and chest wall ports—should provide definitive results...
Eluvia paclitaxel-eluting stent shows long-term freedom from revascularisation at three years
Boston Scientific has announced the three-year results from the MAJESTIC trial for the Eluvia paclitaxel-eluting vascular stent system at the Cardiovascular and Interventional Radiological...
Twelve-month NEAT trial data promising for everlinQ endoAVF haemodialysis access system
TVA Medical has announced the online publication of positive results from the Novel Endovascular Access Trial (NEAT) evaluating its everlinQ endoAVF system. The 12-month...
